Table 3.
Increased ACR in random sample |
Increased ACR in first morning sample |
Increased ACR in random and first morning sample |
Confirmed increased ACR in first morning sample among those with increased ACR in random sample |
|
---|---|---|---|---|
n | 5247 | 5247 | 5247 | 556 |
Overall | 7.7 (6.4–9.1) | 4.7 (3.8–5.6) | 3.6 (2.6–4.5) | 43.5 (35.8–51.2) |
Age 20–49 years | 4.7 (3.9–5.6) | 2.8 (2.0–3.6) | 1.6 (1.0–2.2) | 32.8 (22.4–43.3) |
Age ≥50 years | 11.4 (8.9–13.9) | 7.1 (5.7–8.5) | 6.0 (4.4–7.6) | 48.9 (41.2–56.7) |
Male | 7.2 (5.8–8.6) | 4.6 (3.6–5.5) | 4.0 (3.0–5.0) | 53.1 (41.4–64.9) |
Female | 8.2 (6.4–10.0) | 4.9 (3.5–6.2) | 3.2 (2.0–4.3) | 35.8 (27.5–44.0) |
Hispanic | 9.8 (7.2–12.3) | 5.8 (4.1–7.5) | 5.1 (3.4–6.8) | 49.0 (42.1–55.8) |
Non-Hispanic white | 7.0 (5.3–8.7) | 4.2 (3.0–5.4) | 3.0 (1.9–4.2) | 41.0 (29.0–52.9) |
Non-Hispanic black | 9.9 (7.1–12.7) | 6.2 (4.2–8.2) | 4.7 (3.0–6.5) | 44.50 (35.3–53.7) |
Diabetesb | 24.1 (19.9–28.3) | 15.7 (12.3–19.0) | 15.5 (11.9–19.2) | 56.3 (46.7–65.8) |
No diabetes | 6.2 (4.9–7.5) | 3.7 (2.9–4.5) | 2.5 (1.8–3.3) | 38.9 (30.2–47.6) |
Hypertensionc | 13.7 (11.2–16.3) | 8.4 (6.8–10.0) | 7.8 (6.2–9.4) | 51.5 (43.7–59.3) |
No hypertension | 5.1 (3.9–6.2) | 3.1 (2.2–4.0) | 1.7 (0.9–2.5) | 29.5 (19.7–39.4) |
eGFR,dmL · min−1 · (1.73 m2)−1 | ||||
≥90 | 5.5 (4.3–6.7) | 3.4 (2.5–4.4) | 2.0 (1.2–2.9) | 35.0 (24.9–45.1) |
60–89 | 8.1 (5.8–10.4) | 4.3 (3.0–5.6) | 3.6 (2.2–5.0) | 41.7 (28.1–55.3) |
30–59 | 23.2 (16.6–29.8) | 16.0 (8.9–23.1) | 15.2 (9.1–21.2) | 56.9 (41.1–72.7) |
Data are % (95% CI). Increased ACR defined as ≥30 mg/g. Confirmed albuminuria is defined by the presence of ACR ≥30 mg/g in 2 samples taken within 10 days.
Diagnosed by self-report of diagnosis.
Defined by self-report of diagnosis, self-reported anti-hypertensive treatment, or measured systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg.
Defined by MDRD equation; <30 mL · min−1 · (1.73 m2)−1 not listed owing to small sample size (n = 50).